Life-saving and life-changing GLP-1 drugs like Ozempic and Wegovy have faced recurring shortages. Now, despite being back in stock, affordability is the new crisis. Since expensive name-brand options remain plentiful in stock, cheaper compounded versions will quickly disappear, leaving patients in need without accessible alternatives.

The availability of more expensive options shouldn’t mean the removal of affordable alternatives. This pricing shift will force many to go without essential medication. A mother of three with diabetes told USA Today, "It feels like we're all on an island, and Big Pharma has the only food source, letting those who can't afford it starve."

With prices soaring to $1,300, we cannot stay silent. I urge you to sign this petition to demand affordable access to Semaglutide and other GLP-1 drugs. Life-essential medications should never be out of reach due to cost. Your signature matters—let’s make a change together.